Orange Book product · Brand (NDA)
VANTRELA ER
HYDROCODONE BITARTRATE
At a glance
Jan 17, 2017
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 17, 2017
9 yr 7 mo ago
Today
Patent 9216176 expires
Listed drug product patent expiration.
Sep 13, 2027
in 1 yr 3 mo
Patent 9572803 expires
Listed drug product patent expiration.
Sep 13, 2027
in 1 yr 3 mo
Patent 8445018 expires
Listed drug product patent expiration.
Jul 31, 2029
in 3 yr 2 mo
Pharmaceutical detail
Active ingredient
HYDROCODONE BITARTRATE
Strength
15MG
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 207975
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9216176 | Sep 13, 2027 | in 1 yr 3 mo | Product |
| 9572803 | Sep 13, 2027 | in 1 yr 3 mo | Product |
| 8445018 | Jul 31, 2029 | in 3 yr 2 mo | Product |

